ArticleTranslational vision science & technology2022

Topical Administration of 0.3% Tofacitinib Suppresses M1 Macrophage Polarization and Allograft Corneal Rejection by Blocking STAT1 Activation in the Rat Cornea.

Jianfeng Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.